admin

When Marina Noordegraaf was diagnosed with Parkinson’s disease at age 49, she noticed when it came to treatment decisions, she sometimes felt powerless. She observed that she herself played an active role in communicating her hopes and wishes to her healthcare professionals, which were not automatically taken into account. She took back control by taking
0 Comments
Could the Diabetes Drug Metformin Slow the Aging Process? – Diabetes Daily Learning Center Learning Center: LearningCenter Diabetes Daily does not provide medical advice,diagnosis or treatment.Get additional information.© 2005 – 2023 Everyday Health, Inc., a Ziff Davis company. Everyday Health is among the federally registered trademarks of Everyday Health, Inc. and may not be used
0 Comments
In the UNITE (Urothelial Cancer Network to Investigate Therapeutic Experiences) study, researchers looked at the experience with enfortumab vedotin (EV, Padcev) in patient subsets for which activity had not been well defined in clinical trials. At the recent Genitourinary Cancers Symposium, new findings on biomarkers of response in the trial were presented by Tanya Jindal,
0 Comments
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. A key player in the body’s ability to attack COVID-19 is weakened among people who were infected before getting their first two shots of mRNA vaccine, new research suggests. But even though the key cells (CD8+ T cells) were found to
0 Comments
tofersen Treatment for Amyotrophic Lateral Sclerosis Biogen Provides Update on FDA Advisory Committee Meeting on Tofersen for SOD1-ALS CAMBRIDGE, Mass., March 22, 2023 (GLOBE NEWSWIRE) — Biogen Inc. (Nasdaq: BIIB) announced today the outcome of the U.S. Food and Drug Administration’s (FDA) Peripheral and Central Nervous System Drugs Advisory Committee meeting on tofersen, an investigational
0 Comments
TOKYO, March 21, 2023 /PRNewswire/ — Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., “Astellas”) will present detailed results from the Phase 3 GLOW trial evaluating first-line treatment with zolbetuximab, an investigational first-in-class Claudin 18.2 (CLDN18.2) targeted monoclonal antibody, plus CAPOX (a combination chemotherapy regimen that includes capecitabine and oxaliplatin) versus placebo
0 Comments
Food FARMacias could be one part of the solution to the nation’s growing food insecurity problem, according to a new study by pediatricians at Columbia University Vagelos College of Physicians and Surgeons and NewYork-Presbyterian. Food insecurity-;or lack of enough healthy food for an active, healthy life-;is not just an issue of hunger. Food insecurity prevents
0 Comments
In a recent study published in the Preventing Chronic Disease journal, U.S.  Centers for Disease Control and Prevention (CDC) researchers assessed the impact of the coronavirus disease 2019 (COVID-19) pandemic on the sleep duration and mental health of high school students. The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has altered day-to-day life in
0 Comments
In a recent study published in Nature’s Communications Biology journal, researchers in the United States of America (USA) employed next-generation sequencing (NGS) data to assess the rise in reinfections with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant. Study: Analysis of well-annotated next-generation sequencing data reveals increasing cases of SARS-CoV-2 reinfection with Omicron.
0 Comments
Perinatal care differs by race and ethnicity, with greater disparities in care for more stigmatizing conditions such as depression and substance use, according to a retrospective study. For example, compared with white women, Black women were less likely to receive a prenatal depression screen (OR 0.8, 95% CI 0.7-0.9) and more likely to be given
0 Comments
Sports-related sudden cardiac arrest (Sr-SCA) appears to be extremely rare in women compared with men, despite similar characteristics and circumstances of occurrence, data from three European population-based registries suggest. “Our study shows that cardiac arrest during sports activities is up to 13 times less frequent in women, which means that the risk of sports-related cardiac
0 Comments
Image Source: Getty Images / Jerod Harris / Stringer When you hear terms like “hot-girl hobby” and “‘That Girl’ workout,” racket sports probably aren’t the first things to come to mind. Chances are, you think of people doing reformer Pilates decked out in Lululemon, or those TikTok videos where people share the stylish outfits they’re
0 Comments
FDA Approves Zynyz (retifanlimab-dlwr) for the Treatment of Metastatic or Recurrent Locally Advanced Merkel Cell Carcinoma (MCC) WILMINGTON, Del.–(BUSINESS WIRE)–Mar. 22, 2023– Incyte (Nasdaq:INCY) today announced that the U.S. Food and Drug Administration (FDA) has approved Zynyz™ (retifanlimab-dlwr), a humanized monoclonal antibody targeting programmed death receptor-1 (PD-1), for the treatment of adults with metastatic or
0 Comments
Treatments for open-angle glaucoma are needed. Glaucoma is a leading cause of irreversible blindness, which can be terrifying and significantly affect someone’s quality of life. Unfortunately, this disease is estimated to have damaged the eyesight of over 70 million people worldwide.1 Also, 10% of people who experience blindness in both eyes cannot see as a
0 Comments
In this article BIIB Follow your favorite stocksCREATE FREE ACCOUNT A pedestrian walks past Biogen Inc. headquarters in Cambridge, Massachusetts, U.S., on Monday, June 7, 2021. Adam Glanzman | Bloomberg | Getty Images The Food and Drug Administration’s independent panel of advisors on Wednesday voted against the effectiveness of Biogen’s investigational ALS drug for a
0 Comments
BEIJING, SHANGHAI and BOSTON, March 22, 2023. Jacobio Pharma (1167.HK) announced it has entered into a clinical collaboration with Merck & Co., Inc., Rahway, NJ, USA to evaluate the combination of Jacobio’s CD73 monoclonal antibody JAB-BX102 in combination with Merck & Co., Inc., Rahway, NJ, USA’s anti-PD-1 therapy, KEYTRUDA (pembrolizumab). The clinical study will evaluate
0 Comments
In this article MRNA Follow your favorite stocksCREATE FREE ACCOUNT Moderna CEO Stephane Bancel on Wednesday defended the company’s plans to hike the price of its Covid shots fivefold, deflecting pressure at a Senate hearing to abandon the increase while taking barbs over his compensation. Moderna plans to raise the list price of its vaccine
0 Comments
An analysis of data by researchers at Oxford Population Health’s Cancer Epidemiology Unit has shown that use of progestogen-only hormonal contraceptives is associated with a 20-30% higher risk of breast cancer. The results are published today in PLOS Medicine. Previous studies have shown that use of the combined contraceptive pill, which combines estrogen and progestogen,
0 Comments
Is Your Insulin Getting Less Expensive? Your Comprehensive Guide to the Insulin Price Cuts – Diabetes Daily Learning Center Learning Center: LearningCenter Diabetes Daily does not provide medical advice,diagnosis or treatment.Get additional information.© 2005 – 2023 Everyday Health, Inc., a Ziff Davis company. Everyday Health is among the federally registered trademarks of Everyday Health, Inc.
0 Comments